Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Multiple sclerosis (MS) affects everyone differently, so start by confirming your MS type with your doctor. Consider trusted sources like the National Multiple Sclerosis Society for education. Common ...
Primary progressive multiple sclerosis (PPMS) causes symptoms to worsen from the firt time they appear, without true remissions. Disability progresses over time, even if symptoms sometimes settle.
Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results